Paper39458996
Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics.
Kench U and 4 others. Pharmaceuticals (Basel), 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics. Papers, record 39458996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23-64-10018 | Russian Science Foundation | PubMed | ||
| 22-14-00353 | Russian Science Foundation | PubMed | ||
| 075-15-2019-1660 | Ministry of Science and Higher Education of the Russian Federation | PubMed |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23727157 | Autophagosome formation--the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. | Semin Cancer Biol | 2013 | https://conductscience.org/library/papers/23727157 | PubMed |
| 2 | 30993606 | Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later. | Drugs R D | 2019 | https://conductscience.org/library/papers/30993606 | PubMed |
| 3 | 25512644 | Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. | Haematologica | 2015 | https://conductscience.org/library/papers/25512644 | PubMed |
| 4 | 21148553 | Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21148553 | PubMed |
| 5 | 30975171 | Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30975171 | PubMed |
| 6 | 24374083 | Different effects of Atg2 and Atg18 mutations on Atg8a and Atg9 trafficking during starvation in Drosophila. | FEBS Lett | 2014 | https://conductscience.org/library/papers/24374083 | PubMed |
| 7 | 26585594 | Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26585594 | PubMed |
| 8 | 16874097 | Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations. | Autophagy | 2006 | https://conductscience.org/library/papers/16874097 | PubMed |
| 9 | 24522518 | Corynoxine, a natural autophagy enhancer, promotes the clearance of alpha-synuclein via Akt/mTOR pathway. | J Neuroimmune Pharmacol | 2014 | https://conductscience.org/library/papers/24522518 | PubMed |
| 10 | 20123989 | Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20123989 | PubMed |
| 11 | 19881538 | Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. | Oncogene | 2010 | https://conductscience.org/library/papers/19881538 | PubMed |
| 12 | 22324354 | Obatoclax mesylate : pharmacology and potential for therapy of hematological neoplasms. | Expert Opin Investig Drugs | 2012 | https://conductscience.org/library/papers/22324354 | PubMed |
| 13 | 19325567 | The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. | Cell Death Differ | 2009 | https://conductscience.org/library/papers/19325567 | PubMed |
| 14 | 25482163 | Obatoclax induces Beclin 1- and ATG5-dependent apoptosis and autophagy in adenoid cystic carcinoma cells. | Oral Dis | 2015 | https://conductscience.org/library/papers/25482163 | PubMed |
| 15 | 33524789 | The effects of metformin on autophagy. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33524789 | PubMed |
| 16 | 35053199 | Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations. | Biomolecules | 2021 | https://conductscience.org/library/papers/35053199 | PubMed |
| 17 | 34241570 | Targeting autophagy in disease: established and new strategies. | Autophagy | 2022 | https://conductscience.org/library/papers/34241570 | PubMed |
| 18 | 18330473 | Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. | Acta Biochim Biophys Sin (Shanghai) | 2008 | https://conductscience.org/library/papers/18330473 | PubMed |
| 19 | 25625842 | Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose. | PLoS One | 2015 | https://conductscience.org/library/papers/25625842 | PubMed |
| 20 | 23744296 | Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. | Cell Death Differ | 2013 | https://conductscience.org/library/papers/23744296 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42041531 | Autophagy-Actin Crosstalk: Implications for Cellular Homeostasis and Disease. | Cells | 2026 | https://conductscience.org/library/papers/42041531 | PubMed |
| 41154572 | Roles of Autophagy and Oxidative Stress in Cardiovascular Disease. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41154572 | PubMed |
| 40345900 | Advances in host-directed therapy for tuberculosis and HIV coinfection: enhancing immune responses. | Trends Microbiol | 2025 | https://conductscience.org/library/papers/40345900 | PubMed |
| 40242969 | The role of Bcl‑2 in controlling the transition between autophagy and apoptosis (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40242969 | PubMed |
| 40149885 | Renal Implications of Dysregulated Protein Homeostasis: Insights into Ubiquitin-Proteasome and Autophagy Systems. | Biomolecules | 2025 | https://conductscience.org/library/papers/40149885 | PubMed |
| 40034037 | Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. | Future Med Chem | 2025 | https://conductscience.org/library/papers/40034037 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458996
GET https://conductscience.org/api/papers/v1/39458996/references?page=2